- What's Tisch?
- Stem Cell Trial
- Get Involved
"Because of its closeness to clinical patients and its multidisciplinary research approach, the Tisch MS Research Center offers the ideal environment for the better understanding and treatment of MS."
- Dr. Roberto Alfonso, Assistant Research Scientist
Dr. Alfonso joined the Tisch Multiple Sclerosis Research Center of New York as a Research Associate in January 2020 after completing his postdoctoral training at the Laboratory of Viral Diseases in the National Institutes of Health (NIH) in Bethesda, MD. At the NIH, Dr. Alfonso's research focused on the regulation of Herpes virus gene expression during lytic and latency phases and the discovery of new host-virus interactions. These studies led to a better understanding of the mechanisms involved in the transcription of viral genes and the identification of new antiviral targets.
Dr. Alfonso performed his Ph.D. at the National Center for Biotechnology in Madrid, Spain, where he studied the role of epigenetic host factors in the replication and pathogenesis of influenza virus. At Tisch MSRCNY, Dr. Alfonso's research is directed towards understanding the role of environmental factors for the development of MS and the contribution of the immune system to pathogenesis. He was promoted to Assistant Research Scientist in January, 2021.
Dr. Alfonso works with research assistant Joyce Lei (BA from Cornell University).
Joyce Lei, Vanessa J. Kirschner, Grant Feuer, Michaela Malin, Jiayuan Liu, Morgan Roche, Jerry Lin, Roberto Alfonso, Saud A. Sadiq.Strong T-cell activation in response to SARS-CoV-2 vaccination in patients with multiple sclerosis on B-cell depleting therapies. Presented at the American Academy of Neurology (AAN) Annual Meeting held April 2-7, 2022.
Vanessa J. Kirschner, Grant Feuer, Michaela Malin, Joyce Lei, Jiayuan Liu, Morgan Roche, Jerry Lin, Roberto Alfonso, Saud A. Sadiq. T-cell activation in patients with multiple sclerosis on B-cell depleting therapies is as effective as that of general population in response to SARS-CoV-2 vaccination. Presented virtually at the Society for Neuroscience Annual Meeting 2021.
521 West 57th Street
New York, NY 10019
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.